Intrexon Corporation News Headlines

XON 
$44.635
*  
4.415
10.98%
Get XON Alerts
*Delayed - data as of Mar. 3, 2015 13:29 ET  -  Find a broker to begin trading XON now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    XON Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Intrexon Corp. (XON) Is Challenging The Highs Following Q4 Report
3/3/2015 9:40:00 AM - RTT News


Earnings Reported After The Bell Mar. 2
3/3/2015 4:35:00 AM - RTT News


BMY To Face FDA, XON Springs A Surprise, AERI Awaits Rocket To Deliver
3/3/2015 12:23:00 AM - RTT News


Intrexon (XON) Stock Climbs in After-Hours Trading Today Following Earnings Release
3/2/2015 4:30:00 PM - TheStreet


AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal
3/2/2015 1:42:00 AM - RTT News


Intrexon To Buy Canadian Agriculture Biotechnology Company
2/27/2015 4:50:00 PM - RTT News


Intrexon: Back-End Economics Could Generate Huge Upside
2/27/2015 12:20:00 PM - Seeking Alpha


Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report
2/27/2015 9:00:00 AM - Seeking Alpha


Don't Mimic Warren Buffett - Cramer's Mad Money (2/18/15)
2/19/2015 7:35:00 AM - Seeking Alpha


Pull The Trigger On Acorda - Cramer's Lightning Round (2/18/15)
2/19/2015 6:40:00 AM - Seeking Alpha


Soligenix's SGX943 And SGX101 May Be A Solution For Melioidosis Treatment
2/18/2015 2:08:00 PM - Seeking Alpha


The Guru's Bold Call That I Can't Ignore
2/17/2015 5:00:00 AM - Investopedia


Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update
2/17/2015 3:24:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More
2/6/2015 4:00:00 PM - Seeking Alpha


Why Intrexon And Ziopharm Investors Now Face Increased Risk Both Short And Long-Term
2/3/2015 6:38:00 PM - Seeking Alpha


InsiderInsights.com Daily Round Up 1/27/15: OKSB, OAS, XON, MLNK
1/28/2015 11:20:00 AM - Seeking Alpha


Update: A Dangerous Time To Short Intrexon
1/28/2015 3:42:00 AM - Seeking Alpha


Intrexon To Buy Rest Of Exemplar Genetics
1/26/2015 1:43:00 PM - RTT News


XON Prices Offering At $27/Share
1/22/2015 3:46:00 AM - RTT News


Update: Intrexon Announces Massive Secondary, Should Investors Worry?
1/21/2015 2:41:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


ZIOPHARM, Intrexon Ink CAR T Deal with MD Anderson - Analyst Blog
1/16/2015 4:45:00 AM - Investopedia


Update: Intrexon Expands Partnership With Fibrocell Sciences
1/15/2015 2:13:00 AM - Seeking Alpha


Ziopharm up big on CAR-T license deal
1/14/2015 8:25:00 AM - Seeking Alpha